Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- What are the effects of sodium glucose co‐transporter‐2 (SGLT2), dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 (GLP‐1) agonists for adults with diabetes and chronic kidney disease (CKD)?
- How does tight glycemic control compare with non-tight control for preventing diabetic kidney disease and its progression?
- In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?
- What are the effects of lowered dietary salt intake for preventing diabetic kidney disease and its progression?
- In people with diabetic kidney disease, does pentoxifylline improve outcomes?
O uso deste conteúdo está sujeito ao nosso aviso legal